Adherence to antiretroviral therapy & its determinants amongst HIV patients in India

Indian Journal of Medical Research

Volumn 127, Issue 1, 2008, Pages 28-36

  Sarna, Avina ^a   Pujari, S ^b,g   Sengar, A K ^c   Garg, R ^d   Gupta, I ^e   van Dam, J ^f  

^a POPULATION COUNCIL   (India)

^b Ruby Hall Clinic and Grant Medical Foundation ^*  (India)

^c Ministry of Railways Government of India   (India)

^d Department of Radiology   (India)

^e INSTITUTE OF ECONOMIC GROWTH   (India)

^f POPULATION COUNCIL   (United States)

^g UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Adherence; Antiretroviral therapy (ART); HIV; India; Infected; Limited settings; Resource

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; DEPRESSION; DISEASE SEVERITY; EDUCATION; FEMALE; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; POVERTY; SEMI STRUCTURED INTERVIEW; STRUCTURED QUESTIONNAIRE; UNEMPLOYMENT; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 43449105347     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Blower S, Ma L, Farmer P, Koenig S. Predicting the impact of antiretrovirals in resource-poor settings: prevention of HIV infection whilst controlling drug resistance. Curr Drug Targets Infect Disord 2003; 3: 345-53.
2. Paterson DL, Swindells S, Mohr J, Brester M, Vergis F, Squire C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection'. Ann Intern Med 2000; 133: 21-30.
3. Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM. Preventing antiretroviral anarchy in Africa. Lancet 2001, 358: 410-4.
4. Nemes MI, Carvalho HB, Souza MF. Antiretroviral therapy adherence in Brazil. AIDS 2004; 18 (Suppl 1): S15-20.
5. Orwell C, Bangsberg D, Badri M, Wood R. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS 2003; 17: 1369-75.
6. Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, et al. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses 2004; 20: 1053-6.
7. Gill CJ, Hamer DH, Simon JL, Thea, DM, Sabin LA. No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS 2005; 19: 1243-9.
8. Safren S, Kumarasamy N, James R, Rantinani S, Solomon S, Mayer KH. ART adherence, demographic variables and CD4 outcome among HIV-positive patients on antiretroviral therapy in Chennai, India. AIDS Care 2005; 17: 853-62.
9. Wanchu A, Kaur R, Bamberry P, Singh S. Adherence to generic reverse transcriptase inhibitor-based antiretroviral medication at a tertiary centre in North India. AIDS Behav 2007; 11: 99-102.
10. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000; 30: S171-6.
11. Ickovics JR, Meade CS. Adherence to HAART among patients with HIV. breakthroughs and barriers. AIDS Care 2002; 14: 309-18.
12. Weiss L, French T, Finlestein R, Waters M, Mukerjee R, Agins B. HIV related knowledge and adherence to HAART. AIDS Care 2003; 15: 673-9.
13. Servellen G, Nyamathi A, Carpio F, Pearce D, Garica-Teague L, Herrera G, et al. Effects of a treatment adherence enhancement program on health literacy, patient-provider relationships and adherence to HAART among low-income HIV positive Spanish speaking Latinos. AIDS Patient Care STDS 2005; 19: 745-59.
14. Singh N, Squire C, Sivek M, Wagener M, Nguyen MH, Yu VL, et al. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care 1996; 8: 261-9.
15. Altice FL, Mostashari F, Friedland GH. Trust and acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 28: 47-58.
16. AACTG baseline and follow up adherence questionnaires. Available from: www.fstrf.org./qol/aactg/adult_ql.htm.
17. Weiser SD, Guzman D, Riley ED, Clark R, Bangsberg DR. Higher rates of viral suppression with non-nucleoside reverse transcriptase inhibitors compared to single protease inhibitors are not explained by better adherence. HIV Clin Trials 2004; 5: 278-87.
18. Maggiolo F, Ravasio L, Ripamonti D, Gregis G, Qunizan G, Arici C, et al. Similar adherence rates favor different virologic outcomes for patients treated with non-nucleoside analogues and protease inhibitors. Clin Infect Dis 2005; 40: 158-63.
19. NIAID AACCTG Symptoms Distress Module. Available from: www.fstrf.org/ qol/aactg/adult_ql.htm. Accessed in March 2004.
20. Beck AT. Beck Depression Inventory® - II Manual. 1996. The Psychological Corporation. Harcourt Brace & Company.
21. Laniece I, Ciss M, Desclaux A, Diop K, Mbodj F, Ndiaye B, et al. Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS 2003; 17 (Suppl 30: S103-8.
22. Ivers L, Kendrick D, Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings: A meta-analysis of the published literature. HIV/AIDS. Clin Infect Dis 2005; 41: 217-24.
23. Kumaraswamy N, Safren SA, Raminani SR, Pickard R, James R, Krishnan AKS, et al. Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: A qualitative study. AIDS Patient Care STDs. 2005; 19: 526-37.
24. Gordillo V, delAmo J, Soriano V, Gonzalez-Laihoz J. Socio-demographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999; 13: 1763-9.
25. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV-infection and risk for depressive disorders. Am J Psychiatry 2001; 158: 725-30.
26. Chandra PS, Desai G, Ranjan S. HIV & psychiatric disorders. Indian J Med Res 2005; 121: 451-67.
27. Liu H, Golin C, Miller L, Hays RD, Beck K, Sanadaji S, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001; 134: 968-77.
28. Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic response. J Autoimmune Defic Syndr 2005; 38: 445-8.